PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Meloxicam Capsules | 5mg |
![]() |
30 |
68180-189-06 |
Vivlodex® |
AB |
analgesic |
MemAntine HCl Tablets USP | 5mg |
![]() |
60 |
68180-229-07 |
Namenda® |
AB |
NMDa Receptor antagonist |
Memantine Hydrochloride Extended-Release Capsules | 7mg |
![]() |
30 |
68180-247-06 |
Namenda XR® |
AB |
Central Nervous System Agent |
Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
|
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
Metformin HCl ER Tablets | 500mg |
|
60 |
68180-336-07 |
Fortamet® |
AB |
Biguanide Antihyperglycemics |
Metformin Hydrochloride Extended-Release Tablets USP | 500mg |
![]() |
90 |
68180-338-01 |
Glumetza® |
AB |
Antihyperglycemic |
Mibelas™ | 1 mg/0.02 mg |
![]() |
28 x 3 |
68180-0911-73 |
Minastrin® 24 Fe |
AB |
Oral Contraceptive |
Minocycline Hydrochloride Extended-Release Tablets USP | 55mg |
![]() |
30 |
68180-0460-06 |
Solodyn® |
AB |
Antibiotic |
Mirabegron Extended-Release Tablets | 25mg |
![]() |
30 |
68180-151-06 |
Myrbetriq® |
AB |
Beta-3 Adrenergic Agonist |
Moxifloxacin Ophthalmic Solution USP | 0.5% |
|
3mL (in a 5mL Bottle) |
68180-422-01 |
Vigamox® |
AT2 |
Antibiotic |
Moxifloxacin Ophthalmic Solution USP | 0.5% |
![]() |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
My Way™ | 1.5mg |
![]() |
1 |
68180-0852-11 |
Plan B One-Step® |
AB |
Oral Contraceptive |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.